CJC-1295 (no DAC) guide

At a glance

What the research says

The cited preclinical paper asked whether attaching a GHRH analog to albumin could extend its persistence. Researchers tested conjugates in cultured rat pituitary cells and administered modified peptides subcutaneously to male rats. Outcomes included growth hormone secretion, peptide stability, and evidence of albumin association in plasma.[2]

The selected albumin-binding compound, CJC-1295, remained detectable beyond 72 hours in the rat experiments. Laboratory analysis also identified a peptide-reactive band corresponding to serum albumin. Those observations concern the long-acting modification studied in the paper, rather than a dedicated human investigation of a no-DAC presentation.[2][1]

The no-DAC entry is retained as a separate GHRH-analog identity in the library. Its half-hour input is an extrapolation, not a duration demonstrated by this albumin-binding study. The reference helps explain the structural distinction while leaving direct human pharmacokinetics of the no-DAC form unresolved.[2][1]

Cited amounts

The library records 5 mg as a supplier catalog package amount. This is the total listed in that presentation, not an amount selected for administration. No personal dosing range is inferred from it.[1][3]

Half-life and timing

Thirty minutes equals the stored half hour. The single-starting-quantity sequence reaches one quarter at one hour, one eighth at 90 minutes, and one thirty-second at two and a half hours. These values are generated by repeated division by two. They should be read as an illustration of an uncertain input, not as a newly documented human result. In particular, the extended reference for the with-DAC molecule cannot be used to validate this shorter model by association.[1][5]

Reconstitution

The no-DAC catalog example contains 5 mg. Dividing that total by an assumed 2 mL gives 2.5 mg/mL. If the same listed mass were instead represented in a hypothetical 1 mL, its calculated concentration would double, while its identity and total quantity would be unchanged. This demonstrates why the concentration field needs a volume. Neither hypothetical scenario selects a preparation, and neither numeric result establishes an administration amount for the poorly characterized no-DAC form.[3]

Tracking it in PinPoint

Frequently asked questions

Are CJC-1295 no DAC and with DAC the same calculator input?

Their arithmetic formula is the same, but their compound records are distinct. The no-DAC library value is an extrapolated 0.5 hours, whereas the with-DAC record uses an extended reference. Selecting a name does not make the underlying evidence interchangeable.[1][2]

Why does a CJC-1295 no DAC calculator need the full name?

The qualifier distinguishes this record from the albumin-binding with-DAC form. A shared abbreviation can otherwise conceal a different package reference and timing assumption. Correct arithmetic cannot compensate for choosing the wrong compound identity at the start.[1][5]

Does the no-DAC source establish the half-hour value directly in humans?

The library says no dedicated human study for this form was found and describes the value as extrapolated. The guide therefore labels 0.5 hours as a tracking input rather than presenting it as a directly established human measurement.[1][5]

Can a peptide tracker app record CJC-1295 (no DAC)?

PinPoint's compound library includes CJC-1295 (no DAC). The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][4]

Sources

Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.

1. PinPoint compound library, CJC-1295 (no DAC)Snapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
2. PubMed pharmacology reference 15817669Identity and research summary checked against this document on 5 October 2026. PubMed abstract, retrieved through NCBI EFetch.Retrieved 2026-10-05 · library-reference
3. Supplier catalog package referencePackage amount only; not a clinical amount or endorsement.Retrieved 2026-10-05 · supplier
4. PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
5. Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic
6. FDA CJC-1295 identity assessmentOpening identity checked 5 October 2026. December 2024 briefing, printed pages 5 and 8: distinct forms and GHRH analog identity.Retrieved 2026-10-05 · primary-reference